CH Baktawar Singh Road
Gurugram, Haryana
India
GLP-1 receptor agonists; dulaglutide; non-alcoholic fatty liver; NAFL; nonalcoholic fatty liver disease; NAFLD; MRI-derived proton density fat fraction; MRI-PDFF; hepatic steatosis; NASH; fat mapping; non-alcoholic steatohepatitis; controlled attenuation parameter; liver stiffness measurement
Type 2 diabetes mellitu, fixed-dose combination, dapagliflozin, pioglitazone, India, Pro 1 Study, MASLD, NAFLD